GB201902392D0 - Modular binding proteins - Google Patents
Modular binding proteinsInfo
- Publication number
- GB201902392D0 GB201902392D0 GBGB1902392.8A GB201902392A GB201902392D0 GB 201902392 D0 GB201902392 D0 GB 201902392D0 GB 201902392 A GB201902392 A GB 201902392A GB 201902392 D0 GB201902392 D0 GB 201902392D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- binding proteins
- modular binding
- modular
- proteins
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1902392.8A GB201902392D0 (en) | 2019-02-21 | 2019-02-21 | Modular binding proteins |
PCT/EP2020/054697 WO2020169838A1 (en) | 2019-02-21 | 2020-02-21 | Modular binding proteins |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1902392.8A GB201902392D0 (en) | 2019-02-21 | 2019-02-21 | Modular binding proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201902392D0 true GB201902392D0 (en) | 2019-04-10 |
Family
ID=65999040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1902392.8A Ceased GB201902392D0 (en) | 2019-02-21 | 2019-02-21 | Modular binding proteins |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201902392D0 (en) |
WO (1) | WO2020169838A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11932633B2 (en) | 2018-05-07 | 2024-03-19 | Mirati Therapeutics, Inc. | KRas G12C inhibitors |
EP3908283A4 (en) | 2019-01-10 | 2022-10-12 | Mirati Therapeutics, Inc. | Kras g12c inhibitors |
EP4021444A4 (en) | 2019-08-29 | 2023-01-04 | Mirati Therapeutics, Inc. | Kras g12d inhibitors |
CA3152025A1 (en) | 2019-09-24 | 2021-04-01 | David BRIERE | Combination therapies |
US11702418B2 (en) | 2019-12-20 | 2023-07-18 | Mirati Therapeutics, Inc. | SOS1 inhibitors |
CN114796525B (en) * | 2022-04-25 | 2024-04-02 | 南方科技大学 | Use of inhibitors of cyclin-mediated proteins in tumor therapy |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9206318D0 (en) | 1992-03-24 | 1992-05-06 | Cambridge Antibody Tech | Binding substances |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
US5858657A (en) | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
US5962255A (en) | 1992-03-24 | 1999-10-05 | Cambridge Antibody Technology Limited | Methods for producing recombinant vectors |
DE69230142T2 (en) | 1991-05-15 | 2000-03-09 | Cambridge Antibody Tech | METHOD FOR PRODUCING SPECIFIC BINDING PAIRS |
US6492160B1 (en) | 1991-05-15 | 2002-12-10 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
US6225447B1 (en) | 1991-05-15 | 2001-05-01 | Cambridge Antibody Technology Ltd. | Methods for producing members of specific binding pairs |
ES2136092T3 (en) | 1991-09-23 | 1999-11-16 | Medical Res Council | PROCEDURES FOR THE PRODUCTION OF HUMANIZED ANTIBODIES. |
WO1993011236A1 (en) | 1991-12-02 | 1993-06-10 | Medical Research Council | Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
US5872215A (en) | 1991-12-02 | 1999-02-16 | Medical Research Council | Specific binding members, materials and methods |
US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
EP3004152B1 (en) * | 2013-05-31 | 2020-09-30 | Molecular Partners AG | Designed ankyrin repeat proteins binding to hepatocyte growth factor |
US20190012428A1 (en) | 2015-12-16 | 2019-01-10 | University Of Washington | Repeat protein architectures |
BR112020003377A2 (en) * | 2017-08-18 | 2020-08-25 | Cambridge Enterprise Limited | modular binding proteins |
-
2019
- 2019-02-21 GB GBGB1902392.8A patent/GB201902392D0/en not_active Ceased
-
2020
- 2020-02-21 WO PCT/EP2020/054697 patent/WO2020169838A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2020169838A1 (en) | 2020-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272064A (en) | Binding proteins 1 | |
GB201802201D0 (en) | Binding agents | |
GB201902392D0 (en) | Modular binding proteins | |
IL284664A (en) | Multispecific binding proteins | |
SG11202001420VA (en) | Modular binding proteins | |
GB201802338D0 (en) | Antigen binding proteins | |
EP4083055A4 (en) | Sugar-modified protein | |
IL289122A (en) | Polypeptides | |
IL287555A (en) | Binding molecules | |
SG11202109901TA (en) | Protein binders for irhom2 | |
IL289119A (en) | Polypeptides | |
IL304317A (en) | Tgf-beta-rii binding proteins | |
IL284317A (en) | Pseudofab-based multispecific binding proteins | |
IL289145A (en) | Il1rap binding proteins | |
IL291364A (en) | Antigen binding proteins | |
GB2586918B (en) | Protein Powder | |
IL288561A (en) | Anti-gal9 immune-inhibiting binding molecules | |
GB201919294D0 (en) | Antibodies or binding proteins | |
GB201912882D0 (en) | Ssea-4 binding members | |
GB201906118D0 (en) | Anti-LAG-3 binding molecules | |
GB201919286D0 (en) | Binding proteins | |
GB201714038D0 (en) | Modular binding proteins | |
GB201713316D0 (en) | Modular binding proteins | |
GB201901704D0 (en) | Binding polypeptides | |
GB201912657D0 (en) | Binding members |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |